Re-published courtesy of AnthroMed.org
Author: Lilipoh interviews Mark Allen, MD
“The statistics are dramatic: within a decade or so, more than 500,000 children diagnosed with autism will enter adulthood. …there is an epidemic of these children who are not incarnating typically, and we are all still learning about their gifts and challenges.”
Together, let’s contribute to a new culture of health which addresses the true causes of disease and facilitates the full potential of each human being.
Chemoimmunotherapy in Advanced Renal Cell Carcinoma: A Case Report of a Long-Term Survivor Adjunctly Treated with Viscum album Extracts
Author: Paul G. Werthmann, Lothar Kindermann, Gunver S. Kienle
Cancer of the kidney has a high and rising incidence (12.1/100,000 in Europe) with a male predominance of approximately 2: 1. Risk factors are smoking, obesity, and hypertension.
Long-term survival of a patient with advanced pancreatic cancer under adjunct treatment with Viscum album extracts: A case report
Author:Paul G Werthmann, Robert Kempenich, Gerlinde Lang-Avérous, Gunver S Kienle
Pancreatic cancer (PC) is a common malignancy (incidence 12.6/100.000 in the United States), with a dismal prognosis (5-year survival of 2%), especially in cases of locally advanced disease (median survival of 8-12 mo).
High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series
Author: Tido von Schoen-Angerer, Johannes Wilkens, Gunver S Kienle, Helmut Kiene, Jan Vagedes
There are an estimated 386,000 new cases of bladder cancer reported globally each year, with 150,000 deaths.
Long-term survival of a patient with an inoperable thymic neuroendocrine tumor stage IIIa under sole treatment with Viscum album extract
Author: María Reynel, Yván Villegas, Paul G. Werthmann, Helmut Kiene, Gunver S. Kienle
Thymic neuroendocrine tumor (TNET) is an exceedingly uncommon primary thymic neoplasm with neuroendocrine differentiation [5% of all thymic tumors and 0.4% of all neuroendocrine tumors (NETs); 0.2 cases per million in the United States] that generally presents as a mass within the anterior mediastinum
Intralesional and subcutaneous application of Viscum album L. (European mistletoe) extract in cervical carcinoma in situ A CARE compliant case report
Author: María Reynel, Yván Villegas, Helmut Kiene, Paul G. Werthmann, Gunver S. Kienle
Carcinoma in situ (CIS), the last grade of dysplasia observed before invasive cancer, is defined as cervical intraepithelial neoplasia grade 3 (CIN 3).
Long-term tumor-free survival in a metastatic pancreatic carcinoma patient with FOLFIRINOX/ Mitomycin, high-dose, fever inducing Viscum album extracts and subsequent R0 resection
Author: Paul Georg Werthmann, Pia Inter, Thilo Welsch, Anne-Kathrin Sturm, Robert Grützmann, Markus Debus, Martin-Günther Sterner, Gunver Sophia Kienle
Pancreatic cancer (PC) is a common malignancy (incidence 12.4/100.000 in the US), with poor prognosis (5-year survival of 2%), especially in cases involving metastatic disease (a median survival of 3.7 months and 6.4 months, despite chemotherapy).
Complete remission and long-term survival of a patient with melanoma metastases treated with high-dose fever-inducing Viscum album extract
Author: Paul G. Werthmann, Alexander Hintze, Gunver S. Kienle
Malignant cutaneous melanoma (MCM) is the sixth most common of all cancers and the deadliest of all skin cancers, with increasing incidence worldwide (incidence and mortality are 9.3–10.2 and 1.2–2.0 per 100,000 people, respectively).
Minor regression and long-time survival (56 months) in a patient with malignant pleural mesothelioma under Viscum album and Helleborus niger extracts—a case report
Author: Paul G. Werthmann, Gerhard Saltzwedel, Gunver S. Kienle
Malignant pleural mesothelioma (MPM) is a rare cancer (incidence 1/100,000 in the US) and is typically linked to asbestos exposure [about 80% of all MPM cases (1)]. The prognosis is poor [median survival 7 months (2)].